14 August 2018
Visiongain’ has launched a new pharma report Anti-Ageing Cosmeceuticals 2017-2027: Anti-wrinkle, Anti-stretch Mark, UV Absorbers, Hair, Topical, Invasive, Acne Therapy, Liposuction, Breast Augmentation, Hair Growth, Eyelid Surgery, Botox, Anti-pigmentation, Abdominoplasty, Other Services
Cosmeceuticals are the future generation of cosmetics and personal care industry as they not only improve appearance but also provide necessary nutrients and drug-like properties to the skin. The core properties of cosmeceuticals may be considered as hybrid of traditional cosmetics and medicines or drugs. Technological advancements have resulted in the launch of advanced and more value-added anti-ageing products in the market.
The lead analyst of the report commented “The growth in per capita disposable income, increasing baby boomer population and rising demand in anti-ageing products due to pollution and fluctuating climatic conditions have boosted the growth of anti-ageing cosmeceuticals market. Furthermore, advertisement and promotional activities from companies have strongly influenced the purchasing power and behaviours of consumers.”
Leading companies featured in the report include Allergan PLC, Avon Products Inc.
Beiersdorf AG, Chanel International B.V., Christian Dior SE, Johnson & Johnson, L'ORÉAL S.A., PROCTER & GAMBLE, Revlon Inc., Unilever PLC.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.
12 April 2021
Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.
09 April 2021
The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.
06 April 2021
Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.